Damage of alveolar-capillary barrier, inflammation, oxidative injury, and lung cell apoptosis represent the key features of acute lung injury (ALI). This study evaluated if selective phosphodiesterase (PDE)-4 inhibitor roflumilast can reduce the mentioned changes in lavage-induced model of ALI. Rabbits with ALI were divided into 2 groups: ALI without therapy (A group) and ALI treated with roflumilast i.v. (1 mg/kg; A+R group). One group of healthy animals without ALI served as ventilated controls (C group). All animals were oxygen-ventilated for further 4 h. At the end of experiment, total and differential counts of cells in bronchoalveolar lavage fluid (BALF) and total and differential counts of white blood cells were estimated. Lung edema formation was assessed from determination of protein content in BALF. Pro-inflammatory cytokines (TNFalpha, IL-6 and IL-8) and markers of oxidation (3-nitrotyrosine, thiobarbituric-acid reactive substances) were detected in the lung tissue and plasma. Apoptosis of lung cells was investigated immunohistochemically. Treatment with roflumilast reduced leak of cells, particularly of neutrophils, into the lung, decreased concentrations of cytokines and oxidative products in the lung and plasma, and reduced lung cell apoptosis and edema formation. Concluding, PDE4 inhibitor roflumilast showed potent anti-inflammatory actions in this model of ALI.

Biomedical Center Martin and Department of Physiology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Slovakia

Department of Histology and Embryology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Slovakia

000      

00000naa a2200000 a 4500

001      

bmc19005372

003      

CZ-PrNML

005      

20230112094503.0

007      

ta

008      

190204s2018 xr ad f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.934047 $2 doi

035    __

$a (PubMed)30607971

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Kosutova, P. $u Biomedical Center Martin and Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

245    10

$a Reduction of lung inflammation, oxidative stress and apoptosis by the PDE4 inhibitor roflumilast in experimental model of acute lung injury / $c P. Kosutova, P. Mikolka, M. Kolomaznik, S. Balentova, M. Adamkov, A. Calkovska, D. Mokra

520    9_

$a Damage of alveolar-capillary barrier, inflammation, oxidative injury, and lung cell apoptosis represent the key features of acute lung injury (ALI). This study evaluated if selective phosphodiesterase (PDE)-4 inhibitor roflumilast can reduce the mentioned changes in lavage-induced model of ALI. Rabbits with ALI were divided into 2 groups: ALI without therapy (A group) and ALI treated with roflumilast i.v. (1 mg/kg; A+R group). One group of healthy animals without ALI served as ventilated controls (C group). All animals were oxygen-ventilated for further 4 h. At the end of experiment, total and differential counts of cells in bronchoalveolar lavage fluid (BALF) and total and differential counts of white blood cells were estimated. Lung edema formation was assessed from determination of protein content in BALF. Pro-inflammatory cytokines (TNFalpha, IL-6 and IL-8) and markers of oxidation (3-nitrotyrosine, thiobarbituric-acid reactive substances) were detected in the lung tissue and plasma. Apoptosis of lung cells was investigated immunohistochemically. Treatment with roflumilast reduced leak of cells, particularly of neutrophils, into the lung, decreased concentrations of cytokines and oxidative products in the lung and plasma, and reduced lung cell apoptosis and edema formation. Concluding, PDE4 inhibitor roflumilast showed potent anti-inflammatory actions in this model of ALI.

650    _2

$a akutní poškození plic $x farmakoterapie $x metabolismus $7 D055371

650    _2

$a aminopyridiny $x farmakologie $x terapeutické užití $7 D000631

650    _2

$a zvířata $7 D000818

650    _2

$a apoptóza $x účinky léků $x fyziologie $7 D017209

650    _2

$a benzamidy $x farmakologie $x terapeutické užití $7 D001549

650    _2

$a bronchoalveolární lavážní tekutina $7 D001992

650    _2

$a cyklopropany $x farmakologie $x terapeutické užití $7 D003521

650    _2

$a modely nemocí na zvířatech $7 D004195

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a oxidační stres $x účinky léků $x fyziologie $7 D018384

650    _2

$a inhibitory fosfodiesterasy 4 $x farmakologie $x terapeutické užití $7 D058988

650    _2

$a pneumonie $x farmakoterapie $x metabolismus $7 D011014

650    _2

$a králíci $7 D011817

655    _2

$a časopisecké články $7 D016428

700    1_

$a Mikolka, Pavol. $7 xx0233042 $u Biomedical Center Martin and Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

700    1_

$a Kolomazník, Maroš. $7 xx0233029 $u Biomedical Center Martin and Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

700    1_

$a Balentova, S. $u Department of Histology and Embryology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

700    1_

$a Adamkov, M. $u Department of Histology and Embryology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

700    1_

$a Čalkovská, Andrea $7 mzk2004236811 $u Biomedical Center Martin and Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

700    1_

$a Mokrá, Daniela $7 xx0105806 $u Biomedical Center Martin and Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 4 (2018), s. S645-S654

773    0_

$t Proceedings of the ... Physiological days $x 1802-9973 $g Roč. 94, Suppl. 4 (2018), s. S645-S654 $w MED00183838

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30607971 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y 4 $z 0

990    __

$a 20190204 $b ABA008

991    __

$a 20230112094456 $b ABA008

999    __

$a ok $b bmc $g 1377945 $s 1043577

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2018 $b 67 $c Suppl. 4 $d S645-S654 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

BMC    __

$a 2018 $b 94 $c Suppl. 4 $d S645-S654 $i 1802-9973 $m Proceedings of the ... Physiological days $x MED00183838

LZP    __

$b NLK118 $a Pubmed-20190204